EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Omarigliptin/shikonin combination alleviates cyclosporine-induced nephrotoxicity: The role of sirtuin 1, glucagon-like peptide-1, HMGB1/RAGE/TLR4 signaling, and p38/ERK/JNK MAPKs

Marwa H Abdallah, Hanan Abdelmawgoud Atia, Hemat A Elariny, Amany M Khalifa, Asmaa Saleh, Ahmed M Kabel iD

Human & Experimental Toxicology · 2025

DOI: 10.1177/09603271251394693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human & Experimental Toxicology, 2025. Verfasst von Marwa H Abdallah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, University of Ha'il, Ha'il, Saudi Arabia. Hauptthemen laut MEDLINE: Cyclosporine, Naphthoquinones, Kidney Diseases, Pyrans. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Ha'il.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cyclosporine is a calcineurin inhibitor that is widely used to decrease the incidence of organ transplant rejection and in the management of immunological diseases. However, these effects may be associated with increased incidence of nephrotoxicity. This work aimed to the exploration of the impact of omarigliptin with or without shikonin on a rodent model of cyclosporine nephrotoxicity and the precise determination of the mechanisms that may represent the basis of these effects.

Methods

In a Wistar rat model of cyclosporine-elicited nephrotoxicity, the effect of omarigliptin and shikonin, each alone and in combination, was determined at the level of the biochemical parameters and the histomorphological changes.

Results

Omarigliptin and/or shikonin administered to cyclosporine-injected animals induced a significant restoration of renal functions and glucagon-like peptide-1 (GLP-1) and augmentation of the antioxidant defenses, associated with increased sirtuin 1 expression and its related signaling changes in comparison to animals that received cyclosporine alone. Additionally, omarigliptin and/or shikonin elicited a significant amelioration of the inflammatory response and cellular differentiation and a significant improvement of the renal tissue disruptive changes elicited by cyclosporine. These effects were evident with omarigliptin/shikonin combination when compared to the groups treated with each agent alone.

Conclusion

Omarigliptin/shikonin combination suggests potential therapeutic benefit for the mitigation of cyclosporine nephrotoxicity, possibly via their effects on dipeptidyl peptidase 4 activity and GLP-1 levels with subsequent modulation of the redox status, cellular proliferation, and the inflammatory pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclosporineNaphthoquinonesKidney DiseasesPyransHeterocyclic Compounds, 2-RingAnimalsRats, WistarMaleGlucagon-Like Peptide 1Sirtuin 1RatsSignal TransductionToll-Like Receptor 4KidneyImmunosuppressive Agents

Stichwörter der Autor:innen

cyclosporineimmunomodulationnephrotoxicityomarigliptinratsshikonin

Substanzen

CyclosporineNaphthoquinonesGlucagon-Like Peptide 1Sirtuin 1PyransshikoninHeterocyclic Compounds, 2-Ring2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)-2,6-dihydropyrrolo(3,4-c)pyrazol-5(4H)-yl)tetrahydro-2H-pyran-3-amineToll-Like Receptor 4Tlr4 protein, rat

Autor:innen und Institutionen

  • Department of Pharmaceutics, College of Pharmacy, University of Ha'il, Ha'il, Saudi Arabia.
  • Department of Pharmacology and Toxicology, College of Pharmacy, University of Ha'il, Ha'il, Saudi Arabia.
  • Department of Pathology, College of Medicine, University of Ha'il, Ha'il, Saudi Arabia.
  • Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Pharmacology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.

ORCID-Profile: Ahmed M Kabel

Förderung

  • University of Ha'il

Zitieren

APA

Abdallah, M. H., Atia, H. A., Elariny, H. A., Khalifa, A. M., Saleh, A., & Kabel, A. M. (2025). Omarigliptin/shikonin combination alleviates cyclosporine-induced nephrotoxicity: The role of sirtuin 1, glucagon-like peptide-1, HMGB1/RAGE/TLR4 signaling, and p38/ERK/JNK MAPKs. Human & Experimental Toxicology. https://doi.org/10.1177/09603271251394693

Vancouver

Abdallah MH, Atia HA, Elariny HA, Khalifa AM, Saleh A, Kabel AM. Omarigliptin/shikonin combination alleviates cyclosporine-induced nephrotoxicity: The role of sirtuin 1, glucagon-like peptide-1, HMGB1/RAGE/TLR4 signaling, and p38/ERK/JNK MAPKs. Human & Experimental Toxicology. 2025. doi:10.1177/09603271251394693

BibTeX
@article{Abdallah2025,
  author = {Abdallah, Marwa H and Atia, Hanan Abdelmawgoud and Elariny, Hemat A and Khalifa, Amany M and Saleh, Asmaa and Kabel, Ahmed M},
  title = {Omarigliptin/shikonin combination alleviates cyclosporine-induced nephrotoxicity: The role of sirtuin 1, glucagon-like peptide-1, HMGB1/RAGE/TLR4 signaling, and p38/ERK/JNK MAPKs},
  journal = {Human & Experimental Toxicology},
  year = {2025},
  doi = {10.1177/09603271251394693}
}
Kostenlos starten →